US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

62.22

+0.24880.40%

Post-market: 62.230.0112+0.02%19:30 EDT

Volume:17.65K

Turnover:1.10M

Market Cap:90.51M

PE:- -

High:62.82

Open:62.57

Low:62.22

Close:61.97

52wk High:68.00

52wk Low:36.13

Shares:1.45M

Float Shares:1.45M

Volume Ratio:0.34

T/O Rate:1.21%

Dividend:0.65

Dividend Rate:1.05%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

Simply Wall St.

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live

Circio bolsters board as it advances circular RNA gene therapy platform

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Moderna rises 13.0%

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

Moderately bullish activity in Moderna with shares up 11.44%

Moderna Raised to Peer Perform from Underperform by Wolfe Research

What Happens if Moderna's Cancer Vaccine Works

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

Moderna on Track for Best Month on Record

Early notable gainers among liquid option names on August 25th

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

Binance launches 5 stock perpetuals with 20x leverage

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares

Illumina management to meet virtually with Piper Sandler

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/GNOM/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":62.2188,"timestamp":1789156800000,"preClose":61.97,"halted":0,"volume":17647,"hourTrading":{"tag":"盘后","latestPrice":62.23,"preClose":62.2188,"latestTime":"19:30 EDT","volume":16,"amount":996.7128,"timestamp":1789169408573,"change":0.0112,"changeRate":0.00018,"amplitude":0},"delay":0,"changeRate":0.004014845893174162,"floatShares":1454735,"shares":1454735,"eps":0,"marketStatus":"Market Closed","change":0.2488,"latestTime":"09-11 16:00:00 EDT","open":62.57,"high":62.82,"low":62.2188,"amount":1101644.7337210001,"amplitude":0.009701,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.97,"sharesOutstanding":1094672,"nav":62.3,"aum":93743649.5,"dividendRate":0.010458,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":64.46,"preClose":61.97,"latestTime":"09:03 EDT","volume":120,"amount":7609.2,"timestamp":1789131824178,"change":2.49,"changeRate":0.040181,"amplitude":0.020332},"postHourTrading":{"tag":"盘后","latestPrice":62.23,"preClose":62.2188,"latestTime":"19:30 EDT","volume":16,"amount":996.7128,"timestamp":1789169408573,"change":0.0112,"changeRate":0.00018,"amplitude":0},"volumeRatio":0.34164785535802483,"impliedVol":0.295,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1454735,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.34164785535802483,"shares":1454735,"dividePrice":0.6507,"high":62.82,"amplitude":0.009701,"preClose":61.97,"low":62.2188,"week52Low":36.125,"pbRate":"--","week52High":68,"institutionHeld":0,"latestPrice":62.2188,"eps":0,"divideRate":0.010458,"volume":17647,"delay":0,"ttmEps":0,"open":62.57,"prevYearClose":45.4562,"prevWeekClose":64.26,"prevMonthClose":64.4209,"prevQuarterClose":56.834,"fiveDayClose":64.97,"twentyDayClose":59.0605,"sixtyDayClose":50.0103},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662757992","title":"Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST","url":"https://stock-news.laohu8.com/highlight/detail?id=2662757992","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662757992?lang=en_us&edition=fundamental","pubTime":"2026-08-26 03:24","pubTimestamp":1787685840,"startTime":"0","endTime":"0","summary":"NeoGenomics, Inc. previously announced that Alicia Olivo, EVP, General Counsel & Business Development, would step down as General Counsel in September 2026 and remain with the company until early October 2026 to support the transition.\nThe company also secured a favorable North Carolina court ruling that invalidated key Natera patents, reducing legal friction around its RaDaR ST assay and altering the competitive landscape in molecular residual disease testing.\nWe’ll now examine how this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/court-win-over-natera-patents-could-be-a-game-changer-for-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/court-win-over-natera-patents-could-be-a-game-changer-for-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1988902786.USD","GNOM","BK4196","LU0345770993.USD","LU0012050646.USD","LU0053671581.USD","LU2324357040.USD","LU2065171402.SGD","BK4121","NTRA","LU2065170008.USD","FBT","NEO","LU0345770308.USD","LU2264538146.SGD","LU2065171311.SGD","LU0106261612.USD","HELX","BK4139","LU2065731478.USD","LU2065169927.USD","LU1064131342.USD","LU0963586101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662386751","title":"Moderna Shares Rise After Wolfe Research Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2662386751","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662386751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 02:20","pubTimestamp":1787682053,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) shares were up 13% in Tuesday trading after Wolfe Research upgraded the company's stock to peer perform from underperform.Trading volume stood at 37.2 million shares, compared with a daily average of 13.2 million.Price: 157.12, Change: +18.23, Percent Change: +13.12","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4501","BK4532","MRNX","BK4588","MRNY","WDNA","BK4551","BK4568","BK4585","BK4548","LGHT","MRNA","IDNA","BK4533","GNOM","BK4534","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759663","title":"Circio bolsters board as it advances circular RNA gene therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759663?lang=en_us&edition=fundamental","pubTime":"2026-08-26 01:07","pubTimestamp":1787677640,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has issued an announcement. Circio Holding ASA has strengthened its board of directors as it enters a new development p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-bolsters-board-as-it-advances-circular-rna-gene-therapy-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-bolsters-board-as-it-advances-circular-rna-gene-therapy-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","LFSC","BK4585","IBBQ","FBT","SYNB","BK4505","IBB","TBXU","IE0009354923.USD","BK4139","BK4588","RNA","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037756","title":"Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037756","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037756?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:59","pubTimestamp":1787677140,"startTime":"0","endTime":"0","summary":"1259 ET - Moderna's finding that the mRNA-based vaccine it made with Merck successfully prevented cancer from spreading or returning in melanoma patients is \"a big de-risking event for its personalized therapy approach,\" Wolfe Research analysts write in a note, upgrading the stock to peer perform from underperform. The market's ebullient response may suggest that some traders misunderstood the vaccine as a preventative treatment, they write, and Moderna may still not reach profitability until 2030. Still, the recent data, as well as Moderna's cost-cutting efforts and its patent litigation settlement with Arbutus Biopharma and Genevant Sciences GmbH, lead to a balanced risk/reward at the stock's current levels, the analysts write. Moderna's stock gains 14% to $158.10 and has nearly tripled in value over the past month.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4501","MRNX","BK4533","BK4548","BK4585","MRNA","MRNY","WDNA","IDNA","BK4534","GNOM","BK4568","BK4588","LGHT","BK4532","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662475696","title":"Moderna rises 13.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662475696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662475696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:06","pubTimestamp":1787673960,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) is up 13.0%, or $18.02 to $156.91. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-rises-13-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-rises-13-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","BK4551","BK4139","BK4532","BK4585","IDNA","MRNA","BK4548","BK4534","GNOM","LGHT","MRNY","BK4533","MRNX","BK4501","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756858","title":"Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756858","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756858?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:00","pubTimestamp":1787673623,"startTime":"0","endTime":"0","summary":"Biotech firm Moderna ($MRNA) saw its stock rise 12.5% today, building on a multi-day rally after releasing positive Phase 3 trial data for its pers...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-rises-12-5-today-following-phase-3-mrna-cancer-vaccine-win-with-merck?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-rises-12-5-today-following-phase-3-mrna-cancer-vaccine-win-with-merck?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","IE00BN8TJ469.HKD","MRK","LU2361044865.SGD","LU1291159041.SGD","LU0234572021.USD","LU0289739699.SGD","LU2491050071.SGD","LU2125154935.USD","IE0002141913.USD","LU0265550946.USD","LU0208291251.USD","LU1929549753.HKD","LU1917777945.USD","WDNA","LU1934455277.USD","LU0689626769.HKD","SG9999014567.USD","LU1934455863.HKD","LU0238689110.USD","LU0130102774.USD","BK4516","LGHT","FHLC","LU1093756168.USD","IE0009355771.USD","LU1066053197.SGD","LU2023250843.SGD","LU1430594728.SGD","IHE","LU2468319806.SGD","LU1066051811.HKD","IE00B2B36J28.USD","LU1934455194.USD","LU1066051498.USD","LU1571399168.USD","LU0203347892.USD","HRTS","MRNX","LU0823416689.USD","LU0432979614.USD","BK4588","LU0070302665.USD","LU2324357040.USD","SG9999002232.USD","LU0980610538.SGD","VHT","LU1116320737.USD","SG9999002224.SGD","LU0965509283.SGD","LU1941712264.USD","FTXH","LU0868494708.USD","SG9999015341.SGD","LU0985320562.USD","LU1585245621.USD","LU0868494617.USD","SG9999014542.SGD","LU1983299246.USD","LU0859254822.USD","IE00B4R5TH58.HKD","LU2361044949.HKD","BK4559","LU1037948541.HKD","LU1116320901.HKD","LU2125909247.SGD","LU2357627491.SGD","IE00BBT3K403.USD","LU0266013472.USD","BK4139","JDOC","IXJ","SGXZ57979304.SGD","LU1974910355.USD","LU2125154778.USD","BK4548","LU1066051225.USD","LU1989772840.SGD","LU2089984988.USD","LU1057294990.SGD","RXL","LU0477156953.USD","BK4533","LU1037948897.HKD","LU2361045086.USD","IDNA","LU1201861249.SGD","LU0320765489.SGD","PPH","IE00BJT1NW94.SGD","LU0130517989.USD","LU0861579265.USD","LU2112291526.USD","LU0648001328.SGD","BK4007","BK4532","SG9999001176.USD","LU1093756325.SGD","IE00BLSP4452.SGD","BK4534","LU0203345920.USD","LU1061106388.HKD","SG9999014575.USD","LU2433249047.HKD","LU0965509010.AUD","SG9999015358.SGD","LU0211331839.USD","LU1023059063.AUD","LU1923622614.USD","PAWZ","LU1035773651.USD","SG9999001176.SGD","LU0106261372.USD","LU2125909593.SGD","TRUH","BK4585","XLV","LU0965509101.SGD","LU0058720904.USD","SG9999014559.SGD","LU1989772923.USD","LU2491050154.USD","LU1941712348.USD","LU1989771016.USD","GDOC","LU0122379950.USD","LU0124676726.USD","MRNY","IE00BFTCPJ56.SGD","BK4568","BK4550","BMED","LU2360032135.SGD","LU1162221912.USD","IE00BLSP4239.USD","IYH","LU2491049909.HKD","LU1069347547.HKD","LU0098860793.USD","BK4501","LU2023250504.SGD","SG9999013999.USD","LU0942090050.USD","LU0006306889.USD","GNOM","LU0320765646.SGD","LU1699723380.USD","IE00BSNM7G36.USD","LU2461242641.AUD","LU0265550359.USD","IE000M9KFDE8.USD","LU0965508806.USD","MRNA","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530807","title":"Moderately bullish activity in Moderna with shares up 11.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530807?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:50","pubTimestamp":1787669413,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares up $15.88, or 11.44%, near $154.78. Options volume more than double the daily average wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-11-44-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-11-44-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4501","MRNX","BK4533","BK4548","BK4585","MRNA","MRNY","WDNA","IDNA","BK4534","GNOM","BK4568","BK4588","LGHT","BK4532","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662535777","title":"Moderna Raised to Peer Perform from Underperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662535777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662535777?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:39","pubTimestamp":1787668740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4568","BK4548","BK4588","IDNA","BK4501","BK4551","BK4533","BK4585","MRNX","BK4532","LGHT","BK4534","MRNA","GNOM","BK4139","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662544753","title":"What Happens if Moderna's Cancer Vaccine Works","url":"https://stock-news.laohu8.com/highlight/detail?id=2662544753","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662544753?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:38","pubTimestamp":1787668680,"startTime":"0","endTime":"0","summary":"The latest trial results from Moderna have brought a personalized cancer vaccine within striking distance of reality. The risks are real, but the potential is undeniable: What will it mean if this therapy actually crosses the finish line?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","MRNY","BK4551","LGHT","MRNX","BK4532","BK4533","BK4139","BK4568","BK4548","GNOM","IDNA","BK4585","MRNA","BK4534","BK4588","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758029","title":"Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758029","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758029?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:15","pubTimestamp":1787667315,"startTime":"0","endTime":"0","summary":"• Moderna shares rallied following Wall Street upgrades and positive oncology trial results.\n• Phase 3 INTerpath-001 trial results showed significant reduction in melanoma recurrence.\n• Heavy short-covering activity and bullish technical indicators accelerated the stock's upward move.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262130677-market-movers-mrna-20260825","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","IHE","CANC","JDOC","PJP","ELIS","ILDR","VHT","IE00BN29S564.USD","LU1712237335.SGD","MHIP","LU1221951046.USD","BMED","ELIL","LU2361045086.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","OZEM","RXL","MEDI","LU1974910355.USD","LU2417539215.USD","AGNG","TMED","LGHT","GDOC","FTXH","LLYZ","XLV","LU0823416689.USD","IE0004445239.USD","FHLC","THNR","MEDX","LLII","IYH","CURE","GNOM","TRUH","WDNA","MRNY","LLYX","HRTS","PPH","LU1221951129.SGD","MRNA","MRNX","IDNA","JNJ","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758856","title":"Moderna on Track for Best Month on Record","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758856","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758856?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:00","pubTimestamp":1787666400,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  is currently at $151.90, up $13.01 or 9.37%--On pace for largest percent increase since Aug. 19, 2026, when it rose 176.97%--Currently up three of the past five days--Up 177.09% month-to-date; on pace for best month on record --Up 415.09% year-to-date--Down 68.65% from its all-time closing high of $484.47 on Aug. 9, 2021--Up 514.23% from 52 weeks ago , when it closed at $24.73--Down 12.89% from its 52-week closing high of $174.38 on Aug. 19, 2026--Up 579.34% from its 52-week closing low of $22.36 on Nov. 20, 2025--Traded as high as $154.27--Up 11.07% at today's intraday high--Best performer in the S&P 500 today--Fifth most active stock in the S&P 500 todayAll data as of 9:57:26 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","BK4588","LGHT","WDNA","BK4534","BK4139","BK4533","BK4551","BK4548","MRNY","MRNA","BK4568","BK4532","IDNA","BK4585","MRNX","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758844","title":"Early notable gainers among liquid option names on August 25th","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758844?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:55","pubTimestamp":1787666119,"startTime":"0","endTime":"0","summary":"Notable gainers among liquid option names this morning include Moderna (MRNA) $153.72 +14.83, Super Micro (SMCI) $37.78 +2.61, Marvell (MRVL) $245....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-august-25th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-august-25th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0274383776.USD","LU1861215975.USD","FXL","SMCI","LU0476273544.USD","LU2272731782.SGD","LU2360107168.USD","MVLL","BK4548","LU1992135472.HKD","MRVX","LU2322448957.HKD","MRVL","LU2931357623.SGD","AIS","LU1852331112.SGD","BK4141","LU2458330169.SGD","IE00BBT3K403.USD","LU0444973449.USD","AIFD","BK4515","MRNX","SMCX","SMHX","LU2458330243.SGD","LU1119994496.HKD","BK4533","LU1316542783.SGD","LU1548497426.USD","LU0444971666.USD","LU1046421795.USD","XNTK","IDNA","LU2244417387.USD","IE00BMPRXQ63.HKD","LU2089985449.USD","SMCC","LU1720051108.HKD","BK4568","LU1303367103.USD","WDNA","LU1992135399.USD","LU0056508442.USD","LU2272731600.USD","LU2272731865.HKD","LU1823568750.SGD","LU2322448791.USD","LU0081259029.USD","LU1169590202.USD","BK4170","LU1084165304.USD","LU0127658192.USD","LU0823434583.USD","ARTY","LU0823421333.USD","IE00BMPRXN33.USD","FTXL","BK4543","BK4534","SMCZ","LU2357305700.SGD","LU1642822529.SGD","SMYY","BK4139","IE00BLSP4452.SGD","BK4532","LU2473716301.USD","IE00BN8TJ469.HKD","MRNA","IE00BMPRXR70.SGD","WUGI","LU0053671581.USD","BK4581","IE0004091025.USD","LU2290526834.HKD","SMCY","LU1235294995.USD","LU1989764664.SGD","LU0786609619.USD","BK4588","BK4605","LU1720051017.SGD","GNOM","QQQA","BK4585","GTEK","BK4501","LU1861220033.SGD","LU0823421416.USD","FAI","SMCL","BK4551","MRNY","LU2098885051.SGD","LU0187121727.USD","DTCR","LU1169589451.USD","BK4604","LGHT","FDTX","LU1989764748.USD","LU0823434740.USD","LU0061475181.USD","LU2543165471.USD","LU1815336760.USD","LU0957808578.USD","MRVU","SG9999000418.SGD","LU1261432733.SGD","LU0642271901.SGD","SOXY","IE0004086264.USD","LU0154236417.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662730978","title":"Moderna Shares up 8.4% as Barclays Hikes Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662730978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662730978?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:44","pubTimestamp":1787665459,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4548","IDNA","LGHT","BK4139","MRNA","BK4532","BK4551","WDNA","BK4534","BK4568","GNOM","BK4533","BK4585","MRNY","BK4501","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737518","title":"After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737518","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737518?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:00","pubTimestamp":1787662814,"startTime":"0","endTime":"0","summary":"WSW, NY, August 25th, 2026, FinanceWire Moderna’s cancer news sent its stock up 177% in a single day (NASDAQ:MRNA), from $62.96 to $174.38. Roughly...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QDTE","BK4585","MRNY","NDX","QQQA","QQQJ","QQQ","BK4139","IYW",".IXIC","QID","LGHT","GNOM","MRNX","WDNA","IDNA","BK4568","JEPQ","GPIQ","QYLG","BK4588","ONEQ","QQQM","BK4532","NQmain","BK4534","NVIW.SI","BK4533","QQQY","TQQQ","TQQY","PSQ","MNQmain","BK4551","TECS","BK4501","QQQE","SLXN","FTEC","BK4548","MRNA","QLD","SQQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662336117","title":"Moderna upgraded to Peer Perform from Underperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662336117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662336117?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:46","pubTimestamp":1787651170,"startTime":"0","endTime":"0","summary":"Wolfe Research upgraded Moderna (MRNA) to Peer Perform from Underperform without a price target The firm says the positive melanoma trial de-risks ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4532","BK4139","GNOM","BK4548","MRNY","BK4501","MRNA","BK4588","IDNA","BK4551","MRNX","WDNA","BK4568","BK4533","LGHT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781125","title":"Binance launches 5 stock perpetuals with 20x leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781125","media":"cryptonews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781125?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:21","pubTimestamp":1787642512,"startTime":"0","endTime":"0","summary":"Binance Futures launched five USDT-margined TradFi perpetual contracts on Aug. 25, giving eligible traders leveraged exposure to Trump Media, Moderna and three semiconductor-focused exchange-traded funds.Binance launched five USDT margined perpetual contracts tied to U.S. stocks and leveraged exchange-traded funds.Contracts offer up to 20x leverage, round-the-clock trading and eight-hour funding settlements through Binance Futures.SKUU and SKDD track daily moves in SK Hynix, while RAM references leveraged DRAM exposure.DJT and MRNA perpetuals reference Trump Media and Moderna shares without granting stock ownership rights.Each contract uses USDT for settlement and requires a minimum notional trade worth five dollars.The contracts began trading at five-minute intervals between 09:00 and 09:20 UTC. Binance listed SKUUUSDT, SKDDUSDT, RAMUSDT, DJTUSDT and MRNAUSDT with maximum leverage of 20x.The long fund seeks twice the daily percentage change in SK Hynix’s U.S.-listed depositary receipt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["SKHZ","DJTU","RAM","BK4548","RAMZ","SKHY","BK4516","BK4532","BK4139","MRNX","BK4534","GNOM","HYNX","SKDD","SK","BK4077","IDNA","07709","BK4501","BK4585","TRUMP.USD.CC","BK4547","SKUU","MRNA","SKHU","BK4588","DRAL","BK4551","DJT","SKHA","DRAM","MRNY","BK4533","LGHT","WDNA","SKHX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137520507","title":"Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning","url":"https://stock-news.laohu8.com/highlight/detail?id=1137520507","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137520507?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:02","pubTimestamp":1787630523,"startTime":"0","endTime":"0","summary":"The biotechnology industry is fundamentally driven by clinical milestones—the success or failure of a Phase 3 trial can trigger significant share price swings not only for the companies directly...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4548","BK4533","MRNX","BK4588","MRNA","BK4501","BK4568","159646","MRNY","WDNA","BK4532","XLK","GNOM","BK4534","BK4551","BK4139","LGHT","IDNA","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662020952","title":"Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662020952","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662020952?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:22","pubTimestamp":1787606549,"startTime":"0","endTime":"0","summary":"Guardant Health Co-CEO AmirAli Talasaz disposes of USD 6.35 million in common sharesGuardant Health Co-CEO AmirAli Talasaz sold 37,500 common shares on Aug. 21, 2026 through the Talasaz Family Foundat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9NSL6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4535","LU0320765992.SGD","GNOM","BK4585","PTH","GH","GNMX","BK4551","FFOX","GDOC","HELX","BK4196","EKG","LU0109394709.USD","LU0889565916.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662357209","title":"Illumina management to meet virtually with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2662357209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662357209?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:45","pubTimestamp":1787604320,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held to be held on August 25-26 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, marke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/illumina-management-to-meet-virtually-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/illumina-management-to-meet-virtually-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4585","BK4588","ILMN","LU0029874061.USD","GNOM","LU0128526141.USD","BK4535","BK4121","GNMX","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4534","BK4568","BIB","LU0109394709.USD","LU0320765992.SGD","MRNA","MEDI","BBH","LU2089984988.USD","GILD","LU0122379950.USD","LU2468319806.SGD","IBBQ","IE00BKVL7J92.USD","BMED","IBB","SG9999015986.USD","LU0859254822.USD","IE0002270589.USD","IE00B3T34201.USD","LU1037948541.HKD","LU2324357040.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU0289739699.SGD","BK4532","LU1037948897.HKD","LU1585245621.USD","LU1061106388.HKD","IE00BSNM7G36.USD","WDNA","LU0114720955.EUR","MRNY","LU1934455277.USD","BK4548","IE00B19Z3B42.SGD","GNOM","IDNA","BK4566","LU0965509283.SGD","TBXU","LGHT","LU1057294990.SGD","LU0234570918.USD","LU2357627491.SGD","MRNX","BK4578","TMED","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}